Historical Stock Price
OVID historical stock prices picture
Ovid Therapeutics (OVID) has the following price history information. Looking back at OVID historical stock prices for the last five trading days, on April 15, 2024, OVID opened at $3.21, traded as high as $3.24 and as low as $3.20, and closed at $3.20. Trading volume was a total of 131.90K shares. On April 16, 2024, OVID opened at $3.18, traded as high as $3.23 and as low as $3.15, and closed at $3.17. Trading volume was a total of 138.00K shares. On April 17, 2024, OVID opened at $3.18, traded as high as $3.22 and as low as $3.05, and closed at $3.11. Trading volume was a total of 160.50K shares. On April 18, 2024, OVID opened at $3.12, traded as high as $3.24 and as low as $3.12, and closed at $3.21. Trading volume was a total of 226.80K shares. On April 19, 2024, OVID opened at $3.19, traded as high as $3.29 and as low as $3.17, and closed at $3.23. Trading volume was a total of 176.60K shares.

OVID Historical Stock Prices By Date:

OVID historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ovid Therapeutics shares, starting with a $10,000 purchase of OVID, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/08/2017
End date: 04/19/2024
Start price/share: $12.79
End price/share: $3.23
Dividends collected/share: $0.00
Total return: -74.75%
Average Annual Total Return: -17.96%
Starting investment: $10,000.00
Ending investment: $2,524.55
Years: 6.95
Date Open High Low Close Volume
04/15/2024 $3.21 $3.24 $3.20 $3.20 131.90K
04/16/2024 $3.18 $3.23 $3.15 $3.17 138.00K
04/17/2024 $3.18 $3.22 $3.05 $3.11 160.50K
04/18/2024 $3.12 $3.24 $3.12 $3.21 226.80K
04/19/2024 $3.19 $3.29 $3.17 $3.23 176.60K
Ovid Therapeutics is a biopharmaceutical company focus on reducing seizures and epilepsies and seizure-related neurological disorders. Co.'s pipeline has produced two epilepsy programs with potential mechanisms of action (MoA), and one epilepsy program with a potential MoA. These programs include soticlestat, which is a cholesterol 24 hydroxylase inhibitor. OV350 is a potential direct activator of the K-Cl co-transporter (KCC2) transporter, and is one among many KCC2 activator compounds in its portfolio. OV329 is a GABA aminotransferase inhibitor. Co.'s genetic research programs include OV815, which focuses on the mutations associated with KIF1A-associated neurological disorder.
Date Close
04/15/2024$3.20
04/16/2024$3.17
04/17/2024$3.11
04/18/2024$3.21
04/19/2024$3.23
OVID is categorized under the Healthcare sector; below are some other companies in the same sector:

OVSC Historical Stock Prices
OXBT Historical Stock Prices
OXGN Historical Stock Prices
PACB Historical Stock Prices
PAHC Historical Stock Prices
PATH Historical Stock Prices
PAVM Historical Stock Prices
PAVMW Historical Stock Prices
PBH Historical Stock Prices
PBIO Historical Stock Prices

Also explore: OVID shares outstanding history

Email EnvelopeFree OVID Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


OVID Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.